Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 5/20 | 0.39 |
| ▸ | AGTR2 | P50052 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.37 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9708369 | 0.94 | AGTR1 (0.39) | AGTR1AGTR2KMT2AMEN1TSHR | |
| SCHEMBL9707901 | 0.93 | ADORA3 (0.40) | AGTR1AGTR2 | |
| SCHEMBL9708614 | 0.91 | POLB (0.46) | POLBHIF1AKMT2AMEN1TSHR | |
| SCHEMBL9708372 | 0.91 | AGTR1 (0.39) | AGTR1AGTR2KMT2APDE4APDE4B | |
| SCHEMBL9708234 | 0.91 | AGTR1 (0.41) | AGTR1AGTR2TSHR | |
| SCHEMBL9708557 | 0.91 | DCTPP1 (0.43) | AGTR1AGTR2KMT2AMEN1TSHR | |
| SCHEMBL9707766 | 0.90 | ALDH1A1 (0.42) | AGTR1AGTR2POLB | |
| SCHEMBL9707935 | 0.90 | AGTR1 (0.39) | AGTR1AGTR2 | |
| SCHEMBL9708560 | 0.90 | AGTR1 (0.42) | AGTR1AGTR2 | |
| SCHEMBL9707898 | 0.90 | MAPT (0.38) | AGTR1AGTR2POLBHIF1AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992007852-A1 | BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |